Grifols (GRFS) Interest Coverage Ratio Growth (3y) (2013 - 2019)
Grifols (GRFS) Interest Coverage Ratio Growth (3y) (2013 - 2019) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | -1.75% |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | - |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 40.80% |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 29.85% |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 13.52% |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | -98.43% |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | - |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | 38.88% |
| 10 | Grifols | 5.45 Bn | 4.45 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 85.49% |
| Jun 30, 2018 | -33.41% |
| Dec 31, 2017 | 54.13% |
| Jun 30, 2017 | -99.19% |
| Dec 31, 2016 | -28.18% |
| Sep 30, 2016 | 6.81% |
| Jun 30, 2016 | 7.10% |
| Mar 31, 2016 | -46.63% |
| Dec 31, 2015 | -97.24% |
| Sep 30, 2015 | 19.55% |
| Jun 30, 2015 | 17.43% |
| Mar 31, 2015 | 22.80% |
| Dec 31, 2014 | 45.42% |
| Sep 30, 2014 | 33.18% |
| Jun 30, 2014 | 9,965.41% |
| Mar 31, 2014 | 30.69% |
| Dec 31, 2013 | 70.91% |
| Sep 30, 2013 | -35.35% |